Preparation of thyroid FNA material for routine cytology and BRAF testing: A validation study

Diagnostic Cytopathology

Volumn 38, Issue 3, 2010, Pages 172-176

  Troncone, Giancarlo ^a,b   Cozzolino, Immacolata ^a   Fedele, Maria ^a   Malapelle, Umberto ^a   Palombini, Lucio ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b CEINGE BIOTECNOLOGIE AVANZATE   (Italy)

Author keywords

Fine needle aspirate; Immediate adequacy assessment; Thyroid; V600e BRAF mutation

Indexed keywords

B RAF KINASE; DNA;

ARTICLE; ASPIRATION BIOPSY; ASPIRATION CYTOLOGY; CANCER DIAGNOSIS; CLINICAL EVALUATION; CONTROLLED STUDY; DNA EXTRACTION; EXON; GENE AMPLIFICATION; HUMAN; HUMAN CELL; MUTATIONAL ANALYSIS; PAPANICOLAOU TEST; PRIORITY JOURNAL; SMEAR; THYROID FOLLICULAR CARCINOMA; THYROID NODULE; VALIDATION STUDY;

ADENOCARCINOMA, PAPILLARY; BIOPSY, FINE-NEEDLE; DNA MUTATIONAL ANALYSIS; DNA, NEOPLASM; GOITER, NODULAR; HUMANS; PROTO-ONCOGENE PROTEINS B-RAF; SPECIMEN HANDLING; THYROID GLAND; THYROID NODULE;

EID: 76149105145     PISSN: 87551039     EISSN: 10970339     Source Type: Journal    
DOI: 10.1002/dc.21166     Document Type: Article

References (12)

1. Baloch ZW, Cibas ES, Clark DP, et al. The National Cancer Institute Thyroid fine-needle aspiration state of the science Conference: A summation. Cyto J 2008;5:6.
2. Alexander EK, Heering JP, Benson CB, et al. Assessment of nondiagnostic ultrasound-guided fine needle aspirations of thyroid nodules. J Clin Endocrinol Metab 2002;87:4924-4927.
3. Nasuti JF, Gupta PK, Baloch ZW. Diagnostic value and cost-effectiveness of on-site evaluation of fine-needle aspiration specimens: Review of 5,688 cases. Diagn Cytopathol 2002;27:1-4.
4. Cohen Y, Xing M, Mambo E, et al. BRAF mutation in papillary thyroid carcinoma. J Natl Cancer Inst 2003;95:625-627.
5. Sapio MR, Posca D, Troncone G, et al. Detection of BRAF mutation in thyroid papillary carcinomas by mutant allele-specific PCR amplification (MASA). Eur J Endocrinol 2006;154:341-348.
6. Salvatore G, Giannini R, Faviana P, et al. Analysis of BRAF point mutation and RET/PTC rearrangement refines the fine-needle aspiration diagnosis of papillary thyroid carcinoma. J Clin Endocrinol Metab 2004;89:5175-5180.
7. Xing M, Westra WH, Tufano RP, et al. BRAF mutation predicts a poorer clinical prognosis for papillary thyroid cancer. J Clin Endocrinol Metab 2005;90:6373-6379.
8. Xing M. BRAF mutation in papillary thyroid cancer: Pathogenic role, molecular bases, and clinical implications. Endocr Rev 2007;28:742-762.
9. Filie AC, Asa SL, Geisinger KR, et al. Utilization of ancillary studies in thyroid fine needle aspirates: A synopsis of the National Cancer Institute Thyroid Fine Needle Aspiration State of the Science Conference. Diagn Cytopathol 2008;36:438-441.
10. Baloch ZW, Tam D, Langer J, Mandel S, Livolsi VA, Gupta PK. Ultrasound-guided fine-needle aspiration biopsy of the thyroid: role of on-site assessment and multiple cytologic preparations. Diagn Cytopathol 2000;23:425-429.
11. Troncone G, Russo M, Malapelle U, et al. Cytological and molecular diagnosis of solid variant of papillary thyroid carcinoma: A case report. Cyto J 2008;5:2.
12. Nikiforov YE, Steward DL, Robinson-Smith TM, et al. Molecular testing for mutations in improving the fine needle aspiration diagnosis of thyroid nodules. J Clin Endocrinol Metab 2009;9:2092-2098.